SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing a massive surge following an earnings report that blew past expectations, with the community actively debating whether this signals a genuine turnaround driven by AI and foundry strategy or if the stock is overextended. Traders are reacting to the news with intense bullish sentiment, highlighting a structural breakout, while others are cautioning against the valuation as short-squeeze momentum intensifies.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is experiencing heightened market activity following news that Uber increased its stake in the company and expanded their robotaxi partnership, fueling active community debates over potential short squeeze scenarios versus ongoing concerns regarding cash burn and dilution. Investors are closely monitoring price action as the stock attempts to find a floor amid heavy short interest and speculative betting on a broader recovery.

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc. is experiencing extreme volatility and heavy community engagement following a court verdict where a jury awarded significant damages against a competitor for deceptive practices. Traders are actively debating the stock's potential for a massive short squeeze due to the company's tight float and the scale of the potential legal windfall, while others express caution regarding the long-term collectability of the settlement and the risk of price manipulation.

ASGN Incorporated engages in the provision of information technology services and solutions. It operates through the Commercial and Federal Government segments. The Commercial segment involves the provision of consulting, creative digital marketing, and permanent placement services. The Federal Government segment provides mission-critical solutions. The company was founded on December 30, 1985 and is headquartered in Glen Allen, VA.

ASGN Inc

ASGN Inc. is trending as investors digest the company's rebranding to Everforth (ticker: EFOR) alongside significant stock price volatility. The community remains deeply divided, with some participants viewing the steep sell-off as an attractive buying opportunity based on profitability, while others express strong skepticism, labeling the price action as manipulative and raising concerns over the company's market position.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Starknet is gaining momentum as investors focus on its strong developer activity, recent BTCFi integrations, and a roadmap prioritizing privacy and quantum resistance. Community discussions highlight the project's technical moat in ZK-STARK architecture and its growing revenue metrics, which many see as a catalyst for potential long-term growth despite recent supply-related price headwinds.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing significant volatility and high trading volume following earnings, with the community actively debating whether recent progress in solid-state battery manufacturing justifies the momentum or if the price action is driven by a short squeeze. Investors are heavily focused on the company's expansion into non-automotive sectors like AI data centers and defense, while bulls and bears clash over the long-term viability of their production ramp-up versus concerns about historical share dilution.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Organon & Co.

Organon & Co. is currently the subject of intense M&A speculation, with investors reacting to reports of potential binding acquisition offers from Sun Pharmaceutical and other interested parties. The community is actively debating the credibility of these buyout rumors and potential valuation scenarios, while simultaneously monitoring technical flag patterns and the company's significant debt obligations that complicate a prospective deal.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on massive volume following confirmation of production orders and a direct business relationship with Marvell, fueling investor excitement about its role in AI infrastructure. The community is actively debating the stock's transition from speculative R&D to a commercial scaling phase, with bullish sentiment driven by the company's patented optical interposer technology and anticipated hyperscaler partnerships.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

ASP Isotopes Inc

ASP Isotopes is trending as investors focus on its potential as a critical player in the nuclear and semiconductor supply chain, particularly amid supply chain constraints and geopolitical tensions affecting helium and isotope markets. The community is actively monitoring for milestone updates regarding commercial production and shipments of Si-28 and other isotopes, often expressing frustration over project timelines while remaining bullish on the firm's long-term strategic value.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending following the announcement of its acquisition of LivePerson, a move investors are evaluating as a strategic effort to consolidate voice and digital messaging capabilities into a unified omnichannel AI platform. While bullish community members highlight the immediate expansion of the enterprise customer base and cross-selling potential, the stock is seeing heightened volatility as traders weigh the integration risks and the impact of the deal on the company's valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wells Fargo & Company Forecasts Strong Price Appreciation for Omnicell (NASDAQ:OMCL) Stock

Wells Fargo & Company increased their target price on shares of Omnicell from $52.00 to $55.00 and gave the company an "overweight" rating in a research report on Thursday...

Omnicell (OMCL) Projected to Post Earnings on Tuesday

Omnicell (NASDAQ:OMCL) will be releasing its Q1 2026 earnings before the market opens on Tuesday, April 28. (View Earnings Report at...

Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of "Moderate Buy" from Brokerages

Omnicell, Inc. (NASDAQ:OMCL - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight analysts that are covering the stock, Marketbeat.com reports. One investment...

OPRX Trades at a Discount to Industry: How to Approach the Stock Now?

OptimizeRx trades at a steep discount to peers, but strong AI-driven growth, rising cash flow and DAAP traction look encouraging.

Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026

Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the first quarter 2026, before market open on Tuesday, April 28, 2026. The Company will host a conference call and webcast to discuss...

TEM Stock Gains 17.9% in a Year: Time to Buy, Hold or Sell?

Tempus AI rides on diagnostics growth, AI-driven data demand, and pricing gains - but persistent losses and valuation questions complicate the buy-or-sell call.

Do Options Traders Know Something About Omnicell Stock We Don't?

Investors need to pay close attention to OMCL stock based on the movements in the options market lately. 

Assenagon Asset Management S.A. Has $11.70 Million Stake in Omnicell, Inc. $OMCL

Assenagon Asset Management S.A. increased its holdings in shares of Omnicell, Inc. (NASDAQ:OMCL - Free Report) by 83.6% during the fourth quarter, according to its most recent Form 13F filing with...

JPMorgan Chase & Co. Has $15.69 Million Position in Omnicell, Inc. $OMCL

JPMorgan Chase & Co. cut its position in Omnicell, Inc. (NASDAQ:OMCL - Free Report) by 94.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Should You Continue to Hold OMCL Stock in Your Portfolio?

Omnicell's autonomous pharmacy push and SaaS growth show promise, but rising costs and weak hospital spending cloud its near-term outlook.

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.

Current Price	$36.37
Prev Close	$36.65
Open	$36.91
Dividend Yield	0.00%
50-Day Moving Average	$36.88
Beta	0.87
Avg. Volume	623,898.57
PE Ratio	841.90

52-Week High	$55.00
52-Week Low	$22.66
Market Capitalization	$1.67B
EPS (Annual)	$0.0443
Price to Book	1.33
Revenue Per Employee	$330,962.29

OMCL
Omnicell, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OMCL News

OMCLOmnicell, Inc.